| Original language | English |
|---|---|
| Pages (from-to) | 1241-1245 |
| Number of pages | 5 |
| Journal | Journal of Magnetic Resonance Imaging |
| Volume | 45 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2017 |
Funding
This project was supported in part by grants from AMAG Pharmaceuticals, Inc., and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR001449). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or AMAG Pharmaceuticals. We also thank the Clinical Translational Science Center staff at the University of New Mexico for their tireless dedication to the support of this research.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001449 |
| New Mexico State University, New York University | |
| Center for Clinical and Translational Science, Mayo Clinic | |
| AMAG Pharmaceuticals, Inc |
Keywords
- Ferumoxytol
- osteomyelitis
- superparamagnetic iron oxide nanoparticle
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging